The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting. Topics ranged from pulsed field ablation (PFA) to insertable cardiac monitors, with AI and other technologies also generating interest. All of the data shared at HRS 2024 demonstrated the never-ending innovation in cardiac care, while also […]
Kardium
Kardium shares 1-year Globe pulsed field ablation data
Kardium today announced one-year clinical trial results for its Globe PF pulsed field ablation (PFA) system for treating AFib. Findings from the PULSAR IDE study were presented at the Heart Rhythm Society (HRS) meeting in San Diego. They highlighted the safety and efficacy for Globe, which currently remains under premarket review with the FDA. The […]
The largest medtech funding rounds of 2024
Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support their innovations. Technologies that were supported by hundreds of millions of dollars in 2024 included pulsed-field ablation, brain-computer interfaces (BCIs), AI-enabled surgical software and more. In all, the amount of medtech companies receiving more than […]
Kardium raises $104M for pulsed field ablation system
Kardium today announced that it raised $104 million in a new financing round to support its Globe pulsed field ablation (PFA) system. Existing investor Fidelity Management & Research Company led the round. Funds and accounts advised by T. Rowe Price added follow-on participation and new investor Durable Capital Partners joined as well. The new financing […]
Kardium has positive pulsed field ablation data
Kardium today announced positive one-year outcomes from the first-in-human trial of its Globe pulsed field ablation (PFA) system. Results came out of the PULSE-EU trial of the company’s Globe system. Vancouver, British Columbia-based Kardium had its findings presented at HRS 2024 earlier this month and published in the Heart Rhythm Journal. Dr. Vivek Reddy of […]
Kardium treats first patient in pulsed-field ablation study
Kardium announced today that it successfully treated the first patients in the PULSAR clinical study for its Globe PF pulsed-field ablation (PFA) system. Vancouver, British Columbia-based Kardium recently received FDA investigational device exemption (IDE) to conduct the study. The international, multicenter PULSAR study evaluates the safety and effectiveness of Globe PF for the treatment of […]
Kardium lands CE Mark for mapping and ablation device
Kardium announced that it received CE Mark approval in Europe for its Globe mapping and ablation system for treating atrial fibrillation (AF). Vancouver, B.C.-based Kardium’s spherical Globe catheter is comprised of 122 electrodes to provide electrophysiologists with single-shot pulmonary vein isolation, high-definition mapping and atrial ablation, according to a news release. Approval in Europe came […]
